Prof. Moshe Papa
Prof. Papa, a physician, basic and clinical investigator, teacher and entrepreneur. Completed his medical studies at Tel Aviv medical school magna cum laude in 1976. During 1975 and 1976 he studied at the BI hospital, Harvard Medical School in Boston, USA. After completion his army service as a field surgeon and later as a flight surgeon he was involved in medical research in aviation medicine in the air force. Left the Army in 1983 as a Cptain.
He underwent surgical training in 1983 at the Mount Sinai hospital in NY, and then spent 2 years as a surgical staff fellow at the National Cancer Institute NIH researching (immunotherapy) and as a clinical fellow in surgical oncology under the guidance of Dr. Steve Rosenberg. He later continued his training in surgery as well as colorectal surgery at the University of Toronto and in 1990 and became part of the staff at the Sinai Hospital. In 1992 he returned to Israel as a staff member at the department of surgical oncology at Sheba medical center Tel Aviv Univ. In 1998 he was appointed as an associate professor of surgery at the Sackler School of Medicine at Tel Aviv University.
In 2000 he was appointed as the head of the Surgical Oncology division and the Mierav Breast Service at Sheba and in 2002 became the head of the department of Surgery and surgical oncology as well as the Laboratory for Genetic Applications in Surgery.
In 2007 he was appointed as a full professor of surgery (academic track) at the Sackler School of Medicine at Tel Aviv University. He is involved in the academic advisory board of the Peres academic institute and in 2018 he was appointed as the vice president and as the supervisor of research and development in Magen David Adom .
His major clinical as well as basic research interests involve development of new technologies to treat cancer , such as : Application of a new noninvasive surgical modality – the focused ultrasound in Surgical Oncology, inra-operative radiation, Neo-Adjuvant Chemotherapy, TNF involvement in tumor cachexia and diabetes, Genetics of Breast and Colon Cancer, the impact of the BRCA tumor suppressor gene on the cell cycle check points and susceptibility to Radiation and Chemotherapy and Epidemiologic aspects of Breast Cancer.
He is involved in public education for cancer screening in the communities, as well as in national advisory committees to government in oncology, surgery and high ethics committee(Helsinki) application of research and new technologies in medicine.
Prof. Papa is involved in many Israeli and international business and healthcare innovative projects and served on as a medical adviser on a few investments funds such as "Star". Dr. Papa has experience in: innovation, management, business development, elaboration of medical research, integration of new technologies and communication.